TrialNeuroendocrinology2020
A Phase II Study of Ibrutinib in Advanced Neuroendocrine Neoplasms.
Taymeyah Al-Toubah et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papertrialcites it
TrialNeuroendocrinology2020
Taymeyah Al-Toubah et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.